Western States Node Webinar: Problems Initiating Buprenorphine Treatment Among Patients Using Fentanyl (Feb 25, 2026) CME available!

Join the CTN Western States Node and the Northwest and Pacific Southwest Addiction Technology Transfer Centers (ATTCs) for their next joint webinar, February 25, 2026, 11am-12:30pm PT!

In this session, Erin Winstanley, PhD (CTN Appalachian Node), will describe a NIDA Clinical Trials Network study, CTN-0135, examining clinician-reported challenges with initiating buprenorphine for people using fentanyl, including precipitated or prolonged withdrawal, patient reports that buprenorphine was ineffective, and patient preference for methadone. In response to these challenges, most clinicians surveyed reported modifying their standard induction protocols or patient counseling approaches. Clinicians treating larger patient volumes, seeing a high proportion of patients using fentanyl, or initiating treatment in non-inpatient settings were more likely to report difficulties starting patients on buprenorphine. Dr. Winstanley will present the study results and discuss their implications.

1.5 CME/CE available! For information about credit types and accreditation, as well as learning objectives for this session, download the webinar flyer.

Register for the webinar here!

Posted on February 11, 2026